OPKO Health, Inc. Equity Securities, FV-NI
OPKO Health, Inc. (OPK) had Equity Securities, FV-NI of $543.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Balance Sheet › Assets › Assets, Current › Short-Term Investments
us-gaap:EquitySecuritiesFvNi · last filed 2023-05-03
- 2023-03-31: Equity Securities, FV-NI $543.00K.
- 2022-12-31: Equity Securities, FV-NI $648.00K.
- 2022-09-30: Equity Securities, FV-NI $1.23M.
- 2022-06-30: Equity Securities, FV-NI $1.51M.
| Period end | Equity Securities, FV-NI |
|---|---|
| 2023-03-31 | $543.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $648.00K 10-Q · filed 2023-05-03 |
| 2022-09-30 | $1.23M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.51M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.06M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $4.23M 10-K · filed 2023-02-27 |
| 2021-09-30 | $6.55M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $7.47M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $8.84M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $14.14M 10-K · filed 2022-03-01 |
| 2020-09-30 | $12.72M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $24.78M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $8.99M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $18.87M 10-K · filed 2021-02-18 |
| 2019-09-30 | $9.13M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $20.86M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $27.72M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $26.31M 10-Q · filed 2019-11-05 |
| 2018-09-30 | $22.18M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $22.35M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |